new fda-approved targeted drug for treatment-resistant, er positive her2 negative breast cancer
Published 7 months ago • 3.1K plays • Length 15:00Download video MP4
Download video MP3
Similar videos
-
21:57
new targeted therapy options for er positive, her2 negative, advanced breast cancer
-
25:14
metastatic her2 negative breast cancer: emerging novel treatment strategies
-
1:17
new breast cancer clinical trial: aspirin for node positive her2 negative breast cancer
-
3:05
pi3k inhibitors for the treatment of brain metastases in her2-negative breast cancer
-
1:17
promising breast cancer drug approved by the fda
-
3:24
'tumors just vanished': cancer patients now in remission after drug trial
-
9:53
best food for lung cancer patients, lung repair, lung recovery, lung cleaning and more
-
11:12
her2-low breast cancer: destiny or good science?
-
0:50
fda approves elacestrant (orserdu) for er-positive, her2-negative, esr1-mutated breast cancer
-
5:38
tak-228 plus hormonal therapy for metastatic, er-positive/her2-negative breast cancer
-
2:06
antibody-drug conjugates for her2-low disease: 2023 ku breast cancer year in review
-
1:41
fda expands approval for drug to treat early-stage breast cancer
-
3:00
fda expands approval of breast cancer drug kisqali: what to know
-
0:27
fda approves new breast cancer treatment
-
1:10
dr. hamilton on the fda approval of tucatinib in her2 breast cancer
-
5:31
fda d.i.s.c.o.: olaparib for gbrcam her2-negative metastatic breast cancer
-
0:59
dr. kelly on the fda approval of ribociclib in hr breast cancer
-
15:53
ev-103 study by dr. jonathan rosenberg led to the fda approval of enfortumab pembrolizumab
-
2:46
dr. brufsky on the fda approval of olaparib in brca breast cancer
-
1:33
breast cancer: two new drugs for her2
-
1:29
drug repurposing in her2 breast cancer
-
27:50
new fda-approved treatment for egfrm nsclc first-line! 🙌 groundbreaking approach